Cargando…
Posttransplant Diabetes Mellitus and Immunosuppression Selection in Older and Obese Kidney Recipients
RATIONALE & OBJECTIVE: Posttransplant diabetes mellitus (DM) after kidney transplantation increases morbidity and mortality, particularly in older and obese recipients. We aimed to examine the impact of immunosuppression selection on the risk of posttransplant DM among both older and obese kidne...
Autores principales: | Axelrod, David A., Cheungpasitporn, Wisit, Bunnapradist, Suphamai, Schnitzler, Mark A., Xiao, Huiling, McAdams-DeMarco, Mara, Caliskan, Yasar, Bae, Sunjae, Ahn, JiYoon B., Segev, Dorry L., Lam, Ngan N., Hess, Gregory P., Lentine, Krista L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8767140/ https://www.ncbi.nlm.nih.gov/pubmed/35072042 http://dx.doi.org/10.1016/j.xkme.2021.08.012 |
Ejemplares similares
-
Effect of Early Steroid Withdrawal on Posttransplant Diabetes Among Kidney Transplant Recipients Differs by Recipient Age
por: Ahn, JiYoon B., et al.
Publicado: (2021) -
Kidney Transplantation, Immunosuppression and the Risk of Fracture: Clinical and Economic Implications
por: Kuppachi, Sarat, et al.
Publicado: (2022) -
The Risk of Postkidney Transplant Outcomes by Induction Choice Differs by Recipient Age
por: Ahn, JiYoon B., et al.
Publicado: (2021) -
Center-driven and Clinically Driven Variation in US Liver Transplant Maintenance Immunosuppression Therapy: A National Practice Patterns Analysis
por: Nazzal, Mustafa, et al.
Publicado: (2018) -
Clinical Correlates and Outcomes of Dual Basiliximab and Antithymocyte Globulin Induction in Kidney Transplant Recipients: A National Study
por: Lam, Ngan N., et al.
Publicado: (2021)